Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Journal Article
Number of items: 4.

Journal Article

Kruger, Stephan ORCID: 0000-0002-4138-9863, Boeck, Stefan, Heinemann, Volker, Laubender, Ruediger P., Vehling-Kaiser, Ursula, Waldschmidt, Dirk, Kettner, Erika, Maerten, Angela, Winkelmann, Cornelia, Klein, Stefan, Kojouharoff, Georgi, Gauler, Thomas C., Von Weikersthal, Ludwig Fischer, Clemens, Michael R., Geissler, Michael, Greten, Tim F., Hegewisch-Becker, Susanna, Modest, Dominik P., Stintzing, Sebastian ORCID: 0000-0002-3297-5801 and Haas, Michael (2015). Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104. Acta Oncol., 54 (7). S. 993 - 1001. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1651-226X

Von Einem, Jobst C., Stintzing, Sebastian, Modest, Dominik P., Wiedemann, Michael, Furweger, Christoph and Muacevic, Alexander (2020). Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients. Cureus, 12 (3). PALO ALTO: CUREUS INC. ISSN 2168-8184

von Einem, Jobst C., Peter, Sylvia, Guenther, Christine, Volk, Hans-Dieter ORCID: 0000-0002-7743-6668, Guertz, Gerald, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno and Heinemann, Volker (2017). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1-a phase I, first in human, first in class trial. Oncotarget, 8 (46). S. 80156 - 80167. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

von Einem, Jobst Christian, Guenther, Christine, Volk, Hans-Dieter ORCID: 0000-0002-7743-6668, Gruetz, Gerald, Hirsch, Daniela, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno and Heinemann, Volker (2019). Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial. Int. J. Cancer, 145 (6). S. 1538 - 1547. HOBOKEN: WILEY. ISSN 1097-0215

This list was generated on Sun Nov 24 02:52:15 2024 CET.